World Wires · story 16002 · unverified · 1 source(s)

InflaRx to Present Late-Breaking Pre-clinical Data on Izicopan at Kidney Week 2026

Jena, Germany, Oct. 02, 2026 (GLOBE NEWSWIRE) -- InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics by targ

Open in the desk

Coverage

• InflaRx to Present Late-Breaking Pre-clinical Data on Izicopan at Kidney Week 2026 GlobeNewswire: public companies · tier D · clear net · 2026-10-02 11:30 UTC

What this site indexes